Pharmaceutical

FDA greenlights medical device to combat bladder issues

In the latest edition of STAT's Health Tech newsletter: the FDA greenlights devi...

STAT+: Pharmalittle: FDA approves Pfizer’s RSV vaccine ...

Boehringer Ingelheim is the latest pharma company to sue the federal government ...

STAT+: FDA advisory panel to debate contentious data on...

“The real questions are, how much uncertainty is there in this assessment of ben...

STAT+: Eli Lilly CEO donates big to Mike Pence presiden...

Eli Lilly CEO David Ricks made a major, early donation to a super PAC in support...

How the first Native Hawaiian psychiatrist set a course...

Benjamin Young wanted to encourage others like him to go into medicine — young p...

Republican presidential candidates spar over abortion bans

Republican presidential candidates sparred Wednesday over a controversial questi...

STAT+: FDA panel votes against high blood pressure devi...

An FDA advisory panel delivered a split decision on a surgical system used in a ...

Signal: Porosome files comprehensive patent for therapi...

The biopharma company has filed a comprehensive patent to address cystic fibrosi...

Ocugen plans Phase I/II trials for macular disease gene...

The gene therapy trials in geographic atrophy and Stargardt disease are planned ...

UTHSC researcher to expedite treatments for PTOA

Hongsik Jake Cho is initiating a project to accelerate progress in stem cell tre...

Qualifyze secures funds to transform pharma supply chai...

Qualifyze has secured $12m to improve supply chain compliance in the pharmaceuti...

FDA grants approval for Pfizer’s RSV vaccine

The US FDA has granted approval for Pfizer’s RSV vaccine, Abrysvo, for use in pr...

Leo Pharma to acquire US company Timber Pharmaceuticals

Leo Pharma has entered an agreement for the acquisition of US-based clinical-sta...

AI drug discovery company Genesis Therapeutics wins $20...

The company’s generative and predictive AI-powered drug discovery platform is al...

Halia plans two trials testing its anti-inflammatory le...

Halia Therapeutics is planning to start two Phase II trials evaluating its lead ...

Janssen’s Talvey adds European approval on top of its U...

Janssen’s bispecific antibody received conditional approval as a subcutaneous th...